Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

14.84
Delayed Data
As of 4:00pm ET
 -1.50 / -9.18%
Today’s Change
14.18
Today|||52-Week Range
46.17
-48.17%
Year-to-Date

Today’s Trading

Previous close16.34
Today’s open15.99
Day’s range14.84 - 16.00
Volume863,650
Average volume (3 months)973,612
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)-26.06%
Earnings growth (this year)+22.33%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+123.72%
P/E ratio21.9
Price/Sales6.96
Price/Book6.97

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-2.56-7.47%
IRWDIronwood Pharmaceuti...-0.63-7.47%
ITCIIntra-Cellular Thera...-2.76-9.65%
TXMDTherapeuticsMD Inc-0.41-6.42%
Data as of 4:01pm ET, 02/08/2016

Financials

Next reporting dateFebruary 23, 2016
EPS forecast (this quarter)$0.30
Annual revenue (last year)$222.1M
Annual profit (last year)$38.0M
Net profit margin17.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
John N. Kapoor
Chief Operating Officer &
Executive Vice President
Daniel Brennan
Corporate headquarters
Chandler, Arizona

Forecasts

Partner Offers